Strides Pharma Science Ltd Share Price Today - Strides Pharma Science Ltd Live Updates NSE/BSE

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open1,050

High1,076.9

Low972

Prev. Close1,097.5

Avg. Traded Price1,005.35

Volume14,90,350

MARKET DEPTH

Total bid57109.00

Total ask72820.00

Orders	Qty	Bid
9	107	999
7	64	998.9
3	14	998.8
4	17	998.7
5	19	998.6

Ask	Qty	Orders
999.5	2	11
999.6	2	26
999.7	3	53
999.8	4	38
999.9	5	120

HIGH/LOW

52w

LOW/HIGH

₹972.002 hours ago

₹1076.903 hours ago

LOWER/UPPER CIRCUITS

₹878.00

₹1317.00

Strides Pharma Science Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 8.33%, in the last year to ₹5,009.4 Cr. Its sector's average revenue growth for the last fiscal year was 12.19%.

Price to Earning Ratio,is 16.4, lower than its sector PE ratio of 48.73.

Quarterly Revenue,rose 17.11% YoY to ₹1,433.82 Cr. Its sector's average revenue growth YoY for the quarter was 16.22%.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 10.68%

Net profit growth 5Y CAGR : -26.45%

Strides Pharma Science Ltd Top mutual funds holding

Motilal Oswal BSE Healthcare ETF

3Y Return+22.4%

NAV₹50.43

Bandhan Small Cap Fund-Reg(G)

3Y Return+20.9%

NAV₹49.01

About Strides Pharma Science Limited

Strides Pharma Science Limited is an Indian pharmaceutical company engaged in the development and manufacture of pharmaceutical products with a corporate office in Bengaluru and registered office at Cyber One, Unit No. 902, Vashi, Navi Mumbai as of February 1, 2025. The equity shares are listed on NSE and BSE, and the Group operates across developed and emerging markets through subsidiaries in India and overseas. As of March 31, 2025, the Group comprised 32 subsidiaries, 1 joint venture, and 3 associates, with 3 subsidiaries in India and 29 overseas; total related entities (including JV and associates) were 36. Key milestones in FY25 included completion of a demerger that led to OneSource Specialty Pharma Limited and its subsidiaries ceasing to be part of the Group, acquisition of the remaining 30% in the Swiss subsidiary now renamed Strides Pharma International AG, formation of a new subsidiary in New Zealand, and consolidation of the consumer healthcare structure under the UK holding company with India and USA subsidiaries. The authorised share capital was increased consequent to the amalgamation of Strides Alathur Private Limited into the Company effective September 12, 2024, and issued, subscribed and paid-up equity stood at 92,162,714 shares as of March 31, 2025.

Strides Pharma Science Limited Business Segment

The Company reports consolidated revenue from operations of Rs 4,565.33 crore for FY25 from continuing operations; detailed percentage contribution by therapeutic or business vertical and domestic vs. international split is not disclosed in the cited sections and hence is not presented here in line with instructions.

Strides Pharma Science Limited Key Management

Arun Kumar — Non-Executive Director, Chairperson of the Board.
Badree Komandur — Managing Director & Group CEO.
G Prakash — Partner, Statutory Auditors’ signing partner (B S R & Co. LLP) referenced in reports; not Company management but included in statutory signatories context within the report.
Vikesh Kumar — Group CFO.
Manjula R. — Company Secretary.

Latest Updates on Strides Pharma Science Limited

Final dividend of Rs 4 per equity share recommended for FY25, subject to shareholder approval, with payment timelines and electronic mode compliance noted per SEBI circulars.
Registered office shifted to Cyber One, Unit No. 902, Plot No. 4–6, Sector 30A, Vashi, Navi Mumbai 400 703, effective February 1, 2025.
Risk Management Committee renamed as Risk Management & Sustainability Committee effective May 22, 2025, reflecting integrated oversight of ESG-related risks.
Appointment of Rao, Murthy & Associates as Cost Auditors for FY26, subject to shareholder ratification; remuneration capped at Rs 4.50 lakh plus taxes and expenses.
Proposal to appoint V. Sreedharan & Associates as Secretarial Auditors for FY26–FY30, subject to shareholder approval, replacing the long-standing firm after 10+ years.
Acquisition and corporate actions: completed acquisition of remaining 30% in the Swiss subsidiary (now Strides Pharma International AG) in October 2024; consolidation of Strides Global Consumer Healthcare Limited (UK) to 100% leading to Consumer India and Consumer USA forming part of the Group from August 5, 2024; incorporation of Strides Pharma New Zealand Pty Limited on July 26, 2024; incorporation of Amexel Pte. Ltd. on March 19, 2025.
Scheme of Arrangement executed: OneSource Specialty Pharma Limited and certain subsidiaries ceased to be part of the Group on November 27, 2024; Strides Alathur Private Limited amalgamated with the Company effective September 12, 2024.
FY25 sustainability highlight: Debut Sustainability Report for FY24 and an S&P Global CSA score of 76/100 with Top 10 global ranking; featured in the Global Sustainability Yearbook 2025.

Similar stocks

SUNPHARMA₹1807.50+46.50 (2.64%)

DIVISLAB₹9793.00+129.00 (1.33%)

TORNTPHARM₹4642.80+62.80 (1.37%)

LAURUSLABS₹2366.00+122.00 (5.44%)

ZYDUSLIFE₹1240.00+55.60 (4.69%)

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

What was today's high for Strides Pharma Science Ltd share?

The intraday high for Strides Pharma Science Ltd on the NSE today (30 Oct 2026) was ₹1,076.90. This compares to the 52-week high of ₹1,260.90 recorded on 21 Sep 2026. Today's high was -14.59% below the 52-week high.

What is the highest Strides Pharma Science Ltd share price ever recorded and when?

The all-time high (ATH) for Strides Pharma Science Ltd was ₹1,643.30, recorded on 17 Oct 2024. At the current price of ₹999.20, the stock is trading 39.20% below its all-time high. The all-time low recorded was ₹235.35 on 06 Jan 2010.

How much return has Strides Pharma Science Ltd given in the last 52 weeks?

Strides Pharma Science Ltd has delivered 28.75% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,260.90 on 21 Sep 2026 and a 52-week low of ₹768.65 on 29 Jan 2026. It is currently trading at ₹999.20 as of 30 Oct 2026.

What is the return of Strides Pharma Science Ltd in the past 5 years?

Strides Pharma Science Ltd has delivered a 102.38% absolute return over the past 5 years, equivalent to a CAGR of 15.14% per annum. The stock was priced at ₹493.72 in Oct 2021 and has risen to ₹999.20 as of 30 Oct 2026. An investment of ₹1,00,000 in Strides Pharma Science Ltd five years ago would be worth ₹2,02,380.00 today.

Has Strides Pharma Science Ltd offered any dividend in the past 5 years?

No,Strides Pharma Science Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of 13.00 per share between FY2022 and FY2026, with the most recent dividend of ₹5.00 per share for May 26, with an ex-dividend date of 31 Jul 2026. At the current market price of ₹999.20, the trailing dividend yield of Strides Pharma Science Ltd stands at 5.00%.

What were the most recent reported sales and net income of Strides Pharma Science Ltd?

For Q1 FY27, Strides Pharma Science Ltd reported: Revenue (Net Sales): ₹5826.48 Cr - Down -3.81% year-on-year from ₹6057.35 Cr in Q4 FY26. Net Income (PAT): ₹729.28 Cr - Up 345.96% year-on-year from ₹163.53 Cr in Q4 FY26.

How much return has Strides Pharma Science Ltd given in the last 3 months?

Strides Pharma Science Ltd has delivered a return of 2.30% over the last 3 months. The stock was trading at ₹1,072.80 on 30 Jul 2026 and is currently at ₹999.20 as of 30 Oct 2026, reflecting a Loss of ₹73.60 per share over this period.

What was Strides Pharma Science Ltd's low today on the NSE?

The intraday low for Strides Pharma Science Ltd on the NSE today was ₹972.00. The stock's 52-week low stands at ₹768.65, recorded on 29 Jan 2026. Today's low is 26.46% above the 52-week low, indicating the stock is trading well above its yearly lows.

What is the share price of Strides Pharma Science Ltd?

As of 30 Oct 2026, the share price of Strides Pharma Science Ltd is ₹999.20 on the NSE and ₹999.20 on the BSE. The stock opened at ₹1,087.40, touched a high of ₹1,076.90 and a low of ₹972.00 during today's session.

How much return has Strides Pharma Science Ltd given in the last 6 months?

Over the last 6 months, Strides Pharma Science Ltd has given a return of 5.85%. The stock was priced at ₹1,036.80 on 30 Apr 2026 and has Fallen to ₹999.20 as of 30 Oct 2026, a change of ₹37.60 per share.